Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-07

FDA Approved: VILAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Teva's supplemental application for vilazodone hydrochloride (generic vilazodone) under ANDA 208212.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vilazodone hydrochloride (generic) (Vilazodone hydrochloride)

Snippet

SUPPL AP for VILAZODONE HYDROCHLORIDE (VILAZODONE HYDROCHLORIDE)